Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice

Experimental Dermatology

Volumn 19, Issue 11, 2010, Pages 973-979

  Lerche, Catharina M ^a   Philipsen, Peter A ^a   Poulsen, Thomas ^b   Wulf, Hans Christian ^a  

^a Mental Health Services CPH   (Denmark)

^b Sonderborg Hospital   (Denmark)

Author keywords

Calcipotriol; Clobetasol 17 propionate; Hydrocortisone 17 butyrate; Photocarcinogenesis; Ultraviolet radiation

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; DAIVONE; DERMOVAT; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; HYDROCORTISONE BUTYRATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; RADIATION DOSE; SKIN CARCINOGENESIS; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA;

ADMINISTRATION, TOPICAL; ANIMALS; BODY WEIGHT; CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CLOBETASOL; DERMATOLOGIC AGENTS; FEMALE; HYDROCORTISONE; KAPLAN-MEIER ESTIMATE; MICE; MICE, HAIRLESS; NEOPLASMS, RADIATION-INDUCED; SKIN; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 77958589616     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01034.x     Document Type: Article

References (32)

1. Menter A, Griffiths C E. Current and future management of psoriasis. Lancet 2007: 370: 272-284.
2. Callen J, Chamlin S, Eichenfield L F et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007: 156: 203-221.
3. Ring J, Barker J, Behrendt H et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol 2005: 19: 663-671.
4. Kligman L H, Crosby M J. Topical tretinoin enhances corticosteroid-induced inhibition of tumorigenesis in hairless mice previously exposed to solar simulating radiation. Cancer Lett 1996: 107: 17-22.
5. Lowe N J, Connor M J, Breeding J, Chalet M. Inhibition of ultraviolet-B epidermal ornithine decarboxylase induction and skin carcinogenesis in hairless mice by topical indomethacin and triamcinolone acetonide. Cancer Res 1982: 42: 3941-3943.
6. Bissett D L, Chatterjee R, Hannon D P. Photoprotective effect of topical anti-inflammatory agents against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 1990: 7: 153-158.
7. Pashko L L, Rovito R J, Williams J R, Sobel E L, Schwartz A G. Dehydroepiandrosterone (DHEA) and 3 beta-methylandrost-5-en-17-one: inhibitors of 7, 12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice. Carcinogenesis 1984: 5: 463-466.
8. Internet 2009; Available from: URL:
9. Forbes P D. Relevance of animal models of photocarcinogenesis to humans. Photochem Photobiol 1996: 63: 357-362.
10. Simon G A, Maibach H I. Relevance of hairless mouse as an experimental model of percutaneous penetration in man. Skin Pharmacol Appl Skin Physiol 1998: 11: 80-86.
11. Diffey B L, Jansen C T, Urbach F, Wulf H C. The standard erythema dose: a new photobiological concept. Photodermatol Photoimmunol Photomed 1997: 13: 64-66.
12. Hedelund L, Lerche C, Wulf H C, Haedersdal M. Carcinogenesis related to intense pulsed light and UV exposure: an experimental animal study. Lasers Med Sci 2006: 21: 198-201.
13. Lerche C M, Philipsen P A, Poulsen T, Wulf H C. Topical tacrolimus in combination with simulated solar radiation does not enhance photocarcinogenesis in hairless mice. Exp Dermatol 2008: 17: 57-62.
14. Lerche C M, Philipsen P A, Sehested M, Wulf H C. Photocarcinogenesis of topical tazarotene and isotretinoin alone and in combination with valproic acid in hairless mice. Exp Dermatol 2008: 17: 972-974.
15. Lerche C M, Philipsen P A, Poulsen T, Wulf H C. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation. Exp Dermatol 2009: 18: 246-251.
16. Lerche C M, Philipsen P A, Poulsen T, Wulf H C. Photocarcinogenesis and toxicity of benzoyl peroxide in hairless mice after simulated solar radiation. Exp Dermatol 2009 Aug 23. [Epub ahead of print].
17. Wulf H C, Poulsen T, Brodthagen H, Hou-Jensen K. Sunscreens for delay of ultraviolet induction of skin tumors. J Am Acad Dermatol 1982: 7: 194-202.
18. Hansen A B, Bech-Thomsen N, Wulf H C. In vivo estimation of pigmentation in ultraviolet-exposed hairless mice. Photodermatol Photoimmunol Photomed 1995: 11: 14-17.
19. Petersen A B, Na R, Wulf H C. Sunless skin tanning with dihydroxyacetone delays broad-spectrum ultraviolet photocarcinogenesis in hairless mice. Mutat Res 2003: 542: 129-138.
20. Gribetz C, Ling M, Lebwohl M et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol 2004: 51: 731-738.
21. Lebwohl M, Freeman A K, Chapman M S, Feldman S R, Hartle J E, Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004: 51: 723-730.
22. Zonneveld I M, Rubins A, Jablonska S et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998: 134: 1101-1102.
23. Kyllonen H, Remitz A, Mandelin J M, Elg P, Reitamo S. Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol 2004: 150: 1174-1181.
24. Queille-Roussel C, Paul C, Duteil L et al. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol 2001: 144: 507-513.
25. Reitamo S, Rissanen J, Remitz A et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998: 111: 396-398.
26. Fisher L B, Maibach H I. The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 1971: 103: 39-44.
27. Schoepe S, Schacke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006: 15: 406-420.
28. Faurschou A, Wulf H C. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial. Arch Dermatol 2008: 144: 620-624.
29. Takiwaki H, Shirai S, Kohno H, Soh H, Arase S. The degrees of UVB-induced erythema and pigmentation correlate linearly and are reduced in a parallel manner by topical anti-inflammatory agents. J Invest Dermatol 1994: 103: 642-646.
30. Windholz M, Budavari S, Stroumtsos L Y, Fertig M N. The Merck Index, 9th edn. Rahway, NJ, U.S.A.: Merck and Co., 1976.
31. De Rie M A, Di N S, Brands S, Hansen A B, Bos J D. Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema. Br J Dermatol 2000: 142: 1160-1165.
32. Glaser R, Rowert J, Mrowietz U. Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriatic patients. Br J Dermatol 1998: 139: 148-151.